- Home
- ABT vs TMO Comparison
ABT vs TMO Comparison
Compare ABT & TMO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ABT
- TMO
- Stock Information
- Founded
- ABT 1888
- TMO 1956
- Country
- ABT United States
- TMO United States
- Employees
- ABT N/A
- TMO N/A
- Industry
- ABT Medical/Dental Instruments
- TMO Industrial Machinery/Components
- Sector
- ABT Health Care
- TMO Industrials
- Exchange
- ABT Nasdaq
- TMO Nasdaq
- Market Cap
- ABT 204.9B
- TMO 211.0B
- IPO Year
- ABT N/A
- TMO N/A
- Fundamental
- Price
- ABT $114.21
- TMO $523.89
- Analyst Decision
- ABT Buy
- TMO Strong Buy
- Analyst Count
- ABT 15
- TMO 18
- Target Price
- ABT $129.80
- TMO $650.72
- AVG Volume (30 Days)
- ABT 4.7M
- TMO 2.2M
- Earning Date
- ABT 01-22-2025
- TMO 01-29-2025
- Dividend Yield
- ABT 1.93%
- TMO 0.30%
- EPS Growth
- ABT 12.04
- TMO 4.56
- EPS
- ABT 3.29
- TMO 15.95
- Revenue
- ABT $41,217,000,000.00
- TMO $42,370,000,000.00
- Revenue This Year
- ABT $5.73
- TMO $0.86
- Revenue Next Year
- ABT $7.17
- TMO $5.39
- P/E Ratio
- ABT $34.72
- TMO $32.85
- Revenue Growth
- ABT 3.15
- TMO N/A
- 52 Week Low
- ABT $99.71
- TMO $493.30
- 52 Week High
- ABT $121.64
- TMO $627.88
- Technical
- Relative Strength Index (RSI)
- ABT 46.60
- TMO 44.94
- Support Level
- ABT $111.28
- TMO $508.86
- Resistance Level
- ABT $114.15
- TMO $535.94
- Average True Range (ATR)
- ABT 1.77
- TMO 10.26
- MACD
- ABT -0.28
- TMO 0.76
- Stochastic Oscillator
- ABT 47.56
- TMO 44.81
About ABT Abbott Laboratories
Abbott manufactures and markets cardiovascular and diabetes devices, adult and pediatric nutritional products, diagnostic equipment and testing kits, and branded generic drugs. Products include pacemakers, implantable cardioverter defibrillators, neuromodulation devices, coronary stents, catheters, infant formula, nutritional liquids for adults, continuous glucose monitors, and immunoassays and point-of-care diagnostic equipment. Abbott derives approximately 60% of sales outside the United States.
About TMO Thermo Fisher Scientific Inc
Thermo Fisher Scientific sells scientific instruments and laboratory equipment, diagnostics consumables, and life science reagents. The firm operates through four segments as of mid-2024 (revenue figures include some cross-segment revenue): analytical technologies (17% of sales); specialty diagnostic products (11%); life science solutions (22%); and lab products and services, which includes CRO services (54%).